BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 909056)

  • 1. Dilatation of the mesenteric vascular bed of the dog produced by a peptide, urotensin I.
    MacCannell K; Lederis K
    J Pharmacol Exp Ther; 1977 Oct; 203(1):38-46. PubMed ID: 909056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of a specific mesenteric vasodilator peptide, urotensin I, to reduce afterload in the dog.
    MacCannell K; Giraud G; Lederis K; Groves G
    Can J Physiol Pharmacol; 1980 Dec; 58(12):1412-7. PubMed ID: 7237239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mammalian pharmacology of the fish neuropeptide urotensin I.
    MacCannell KL; Lederis K
    Fed Proc; 1983 Jan; 42(1):91-5. PubMed ID: 6848383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential antagonism of alpha-1 and alpha-2 adrenoceptor-mediated pressor responses by urotensin I, a selective mesenteric vasodilator peptide.
    Bolt GR; Itoh H; Lederis K; MacCannell KL
    J Pharmacol Exp Ther; 1987 Jul; 242(1):284-91. PubMed ID: 3039111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic, pulmonary and coronary haemodynamic actions of the novel dopamine receptor agonist in awake pigs at rest and during treadmill exercise Z1046.
    Duncker DJ; Haitsma DB; van der Geest IE; Stubenitsky R; van Meegen JR; Man in't Veld AJ; Verdouw PD
    Br J Pharmacol; 1997 Mar; 120(6):1101-13. PubMed ID: 9134223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of urotensin I on afterload redcution by specific dilatation of the mesenteric vascular bed.
    MacCannell KL; Lederis K; Giraud G
    Proc West Pharmacol Soc; 1977; 20():143-7. PubMed ID: 911380
    [No Abstract]   [Full Text] [Related]  

  • 7. Corticotropin releasing factor-like peptides produce selective dilatation of the dog mesenteric circulation.
    MacCannell KL; Hamilton PL; Lederis K; Newton CA; Rivier J
    Gastroenterology; 1984 Jul; 87(1):94-102. PubMed ID: 6327456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Action of sauvagine on the mesenteric vascular bed of the dog.
    Melchiorri P; Negri L
    Regul Pept; 1981 Apr; 2(1):1-13. PubMed ID: 7232774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of selective mesenteric dilator peptides to examine the role of the intestine in experimental hemorrhagic shock.
    MacCannell KL; Newton CA
    Circ Shock; 1985; 17(3):195-203. PubMed ID: 4075506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasodilator effect of adrenomedullin and calcitonin gene-related peptide receptors in rat mesenteric vascular beds.
    Nuki C; Kawasaki H; Kitamura K; Takenaga M; Kangawa K; Eto T; Wada A
    Biochem Biophys Res Commun; 1993 Oct; 196(1):245-51. PubMed ID: 8216298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasodilator activity of endothelin-1 and endothelin-3: rapid development of cross-tachyphylaxis and dependence on the rate of endothelin administration.
    Le Monnier de Gouville AC; Lippton H; Cohen G; Cavero I; Hyman A
    J Pharmacol Exp Ther; 1990 Sep; 254(3):1024-8. PubMed ID: 2118569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-adrenergic tone in the coronary circulation of the conscious dog.
    Vatner SF
    Fed Proc; 1984 Nov; 43(14):2867-72. PubMed ID: 6092145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of a specific and a nonspecific vasodilator on regional blood flows in experimental heart failure.
    MacCannell KL; Giraud GD; Lederis K; Hamilton PL; Groves G
    Can J Physiol Pharmacol; 1982 Feb; 60(2):174-83. PubMed ID: 7083066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors influencing the vascular action of dopamine in the canine mesenteric bed.
    Dóbi I; Kékesi V
    Acta Chir Hung; 1989; 30(4):251-60. PubMed ID: 2561778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological studies with the alpha 2-adrenoceptor antagonist midaglizole. Part I: Respiratory and cardiovascular systems.
    Hirohashi M; Takasuna K; Yamashita N; Tamura K
    Arzneimittelforschung; 1991 Jan; 41(1):9-18. PubMed ID: 1675573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac, coronary and peripheral vascular effects of acetyl glyceryl ether phosphoryl choline in the anesthetized dog.
    Sybertz EJ; Watkins RW; Baum T; Pula K; Rivelli M
    J Pharmacol Exp Ther; 1985 Jan; 232(1):156-62. PubMed ID: 3917504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of cerebroventricular administration of ouabain on renal hemodynamics in anesthetized dogs: evidence for the participation of renal dopaminergic vasodilator fibers.
    Hom GJ; Jandhyala BS
    J Pharmacol Exp Ther; 1984 Aug; 230(2):275-83. PubMed ID: 6747837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reflex limb dilatation following norepinephrine and angiotensin II in conscious dogs.
    Vatner SF; McRitchie RJ
    Am J Physiol; 1976 Mar; 230(3):557-63. PubMed ID: 1266958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of intestinal peptide mixture G2 and vasoactive intestinal peptide VIP on splanchnic circulation in the dog.
    Thulin L; Olsson P
    Acta Chir Scand; 1973; 139(8):691-7. PubMed ID: 4272344
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacological studies of a newly synthetized 1,4-dihydropyridine derivative, 2,6-dimethyl-3,5-dimethoxycarbonyl-4- (o-difluoromethoxyphenyl)-1,4-dihydropyridine (PP-1466).
    Toribatake T; Fujii K; Kobayashi M; Okumura M; Aikawa K
    Arzneimittelforschung; 1985; 35(4):680-6. PubMed ID: 4015734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.